scholarly article | Q13442814 |
P50 | author | Eleanor J. Barnes | Q32637041 |
Michael Pavlides | Q43405332 | ||
William T Clarke | Q64947588 | ||
Christina Levick | Q81401925 | ||
P2093 | author name string | Christopher T Rodgers | |
Matthew D Robson | |||
Ladislav Valkovič | |||
Lucian A B Purvis | |||
Jeremy F Cobbold | |||
P2860 | cites work | Biliary drainage for obstructive jaundice enhances hepatic energy status in humans: a 31-phosphorus magnetic resonance spectroscopy study | Q28344367 |
The Generalization of `Student's' Problem when Several Different Population Variances are Involved | Q30053530 | ||
Human cardiac 31P magnetic resonance spectroscopy at 7 Tesla | Q30433854 | ||
Coil combination for receive array spectroscopy: Are data-driven methods superior to methods using computed field maps? | Q30487745 | ||
The burden of liver disease in Europe: a review of available epidemiological data | Q30590517 | ||
BISTRO: an outer-volume suppression method that tolerates RF field inhomogeneity. | Q30653021 | ||
Cramér-Rao bounds: an evaluation tool for quantitation | Q30654307 | ||
Repeatability of (31) P MRSI in the human brain at 7 T with and without the nuclear Overhauser effect | Q31030888 | ||
MR spectroscopy of the liver: principles and clinical applications. | Q33517208 | ||
The NMR phased array | Q34279090 | ||
Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models | Q34410029 | ||
In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts | Q35350908 | ||
Phospholipid metabolites as indicators of cancer cell function | Q35538301 | ||
Variability of grade and stage in simultaneous paired liver biopsies in patients with hepatitis C. | Q35770548 | ||
Understanding the discrepancies between 31P MR spectroscopy assessed liver metabolite concentrations from different institutions | Q36895806 | ||
The trouble with quality filtering based on relative Cramér-Rao lower bounds | Q38370857 | ||
Endoplasmic reticulum: the major contributor to the PDE peak in hepatic 31P-NMR spectra at low magnetic field strengths | Q41095338 | ||
The variation of pathological changes in the liver evaluated by double biopsies | Q41434143 | ||
Phosphatidylcholine contributes to in vivo (31)P MRS signal from the human liver | Q41598538 | ||
Sampling Variability on Percutaneous Liver Biopsy | Q41604098 | ||
Characterization of the peak at 2.06 ppm in (31) P magnetic resonance spectroscopy of human liver: phosphoenolpyruvate or phosphatidylcholine? | Q41717341 | ||
A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver. | Q42286656 | ||
Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling | Q42959190 | ||
Etiology and functional status of liver cirrhosis by 31P MR spectroscopy | Q43083187 | ||
Receive array magnetic resonance spectroscopy: Whitened singular value decomposition (WSVD) gives optimal Bayesian solution | Q43107465 | ||
Accurate phosphorus metabolite images of the human heart by 3D acquisition-weighted CSI. | Q43589403 | ||
Reproducibility of 31P cardiac magnetic resonance spectroscopy at 3 T. | Q43863042 | ||
Adenine nucleotide content of human liver. Normal values and fructose-induced depletion | Q43965684 | ||
Abnormal hepatic energy homeostasis in type 2 diabetes | Q44899671 | ||
Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. | Q44964478 | ||
Phosphodiesters in the liver: the effect of field strength on the 31P signal | Q45105644 | ||
Assessment of (31)P relaxation times in the human calf muscle: a comparison between 3 T and 7 T in vivo. | Q45969259 | ||
Three-dimensional high-resolution magnetic resonance spectroscopic imaging for absolute quantification of 31P metabolites in human liver | Q46159096 | ||
Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study | Q46369805 | ||
Quantitative ATP synthesis in human liver measured by localized 31P spectroscopy using the magnetization transfer experiment | Q46971368 | ||
Feasibility of liver weight estimation by postmortem computed tomography images: an autopsy study | Q47447604 | ||
Sampling variability of liver fibrosis in chronic hepatitis C. | Q48583601 | ||
One-dimensional image-selected in vivo spectroscopy localized phosphorus saturation transfer at 7T. | Q51118845 | ||
Influence of different fasting periods on P-31-MR-spectroscopy of the liver in normals and patients with liver metastases. | Q51583663 | ||
Assessment of absolute metabolite concentrations in human tissue by 31P MRS in vivo. Part II: Muscle, liver, kidney. | Q51593287 | ||
Ultrashort TE chemical shift imaging (UTE-CSI). | Q51979467 | ||
Standard liver volume in the Caucasian population. | Q52205356 | ||
31P MRSI and 1H MRS at 7 T: initial results in human breast cancer | Q57096859 | ||
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease | Q58622754 | ||
[The effect of nutritional status on the 31P MR spectrum of the normal liver] | Q68481310 | ||
Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver | Q69877786 | ||
Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances | Q72511278 | ||
31P magnetic resonance spectroscopy of the liver: correlation with standardized serum, clinical, and histological changes in diffuse liver disease | Q72511313 | ||
Ternary and Quaternary Aqueous Systems Containing Bile Salt, Lecithin, and Cholesterol | Q72921002 | ||
Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear Overhauser effect enhanced 31P NMR spectra localized by three-dimensional chemical shift imaging | Q73029507 | ||
A new method for absolute quantitation of MRS metabolites | Q73585100 | ||
Improved preservation solutions for organ storage: a dynamic study of hepatic metabolism | Q78164630 | ||
Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy | Q80655378 | ||
Liver biopsy | Q83395480 | ||
A comparison of single-voxel clinical in vivo hepatic 31P MR spectra acquired at 1.5 and 3.0 Tesla in health and diseased states | Q85200802 | ||
Quantitative liver 31P magnetic resonance spectroscopy at 3T on a clinical scanner | Q86999725 | ||
In vivo (31)P magnetic resonance spectroscopy of the human liver at 7 T: an initial experience | Q87421186 | ||
Application of localized ³¹P MRS saturation transfer at 7 T for measurement of ATP metabolism in the liver: reproducibility and initial clinical application in patients with non-alcoholic fatty liver disease | Q87476143 | ||
P433 | issue | 6 | |
P304 | page(s) | 2095-2105 | |
P577 | publication date | 2017-02-28 | |
P1433 | published in | Magnetic Resonance in Medicine | Q6731496 |
P1476 | title | Phosphodiester content measured in human liver by in vivo 31 P MR spectroscopy at 7 tesla | |
P478 | volume | 78 |
Q57020624 | Absolute Quantification of Phosphor-Containing Metabolites in the Liver Using P MRSI and Hepatic Lipid Volume Correction at 7T Suggests No Dependence on Body Mass Index or Age |
Q47191918 | Assessing tissue metabolism by phosphorous-31 magnetic resonance spectroscopy and imaging: a methodology review. |
Q88085964 | Contributions of Magnetic Resonance Imaging to Gastroenterological Practice: MRIs for GIs |
Q64071539 | Feasibility of absolute quantification for P MRS at 7 T |
Q33817177 | In-vivo31P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism. |
Q90683753 | Low SAR 31 P (multi-echo) spectroscopic imaging using an integrated whole-body transmit coil at 7T |
Q42362596 | OXSA: An open-source magnetic resonance spectroscopy analysis toolbox in MATLAB. |
Q48122478 | Using a whole-body 31P birdcage transmit coil and 16-element receive array for human cardiac metabolic imaging at 7T. |
Search more.